본문 바로가기
KERD
논문KCI 등재

구강편평세포암종에서의 Cisplatin 유도 아폽토시스에서의 NF-κB의 활성화

ACTIVATION OF NF-κB IN THE CISPLATIN-INDUCED APOPTOSIS OF ORAL SQUAMOUS CELL CARCINOMA

김종렬|성일용|서종천
대한구강악안면외과학회 (Korean Association Of Oral And Maxillofacial Surgeons)|2006.04|대한구강악안면외과학회지 (Journal of the Korean Association of Oral and Maxillofacial Surgeons)|제32권 제2호|pp. 94-100

2

조회

0

다운로드

1

인용

0

참고문헌

주제분류치의학

초록

Abstract

Purpose: This study was done to confirm the role of NF-κB in cisplatin-induced apoptosis of oral squamous cell carcinoma. Materials and Methods: Five cell lines originated from different oral cancer patients were tested for the apoptosis by the treatment of cisplatin. These cells showed different degree of cisplatin-resistance and the order is OSCC-2> OSCC-3> OSCC-5> OSCC-1> OSCC-4. OSCC-2 and OSCC-4 cells were assayed for the apoptosis by measuring DNA fragmentation and TUNEL staining after cisplatin treatment. While OSCC-4 cells showed apoptosis, OSCC-2 cells showed no or very slight apoptosis by cisplatin treatment. Next, It was determined whether NF-κB activation is required in mediating cisplatin-induced apoptosis of OSCC-4 . Result: The result was that elevated NF-κB activity mediated cisplatin-induced apoptosis. Conclusion: In conclusion, these findings suggest that NF-κB activation is essential to cisplatin-induced apoptosis and it may be involved in cisplatin resistance in OSCC cells.

참고문헌 (33)

  1. "Cellular pharmacology of cisplatin per-spectives on mechanisms of acquired resistance", pp.35~43
  2. "Influence of the proto-oncogene c-fos oncisplatin sensitivity", 59(4), pp.337~345 (2000)
  3. "The Rasfarnesylation inhibitor BZA-5B increases the resistance to cisplatin ina human melanoma cell line", 17, pp.2347~2352 (1997)
  4. "Activation of programmed cell death by anticanceragents cisplatin as a model system", pp.8 275~9 80
  5. "Increase of theresistance of human cervical carcinoma cells to cisplatin by inhibitionof the MEK to ERK signaling pathway partly via enhancement ofanticancer drug-induced NF kappa B activation", 15(63), pp.1423~1430 (2002)
  6. "TC21 mediates transfor-mation and cell survival via activation of phosphatidylinositol 3-kinase", Akt and NF-kappaB signaling pathway, 2002, pp.7(21), 1062~1070
  7. "Aberrant rel", nfkb genes and activity in humancancer, 2006, pp.32, 94~100
  8. "Upregulation of Bcl-xand Bfl-1 as a potential mechanism of chemoresistance which can beovercome by NF-kappaB inhibition", 5(19), pp.4936~4940 (2000)
  9. "NF-kappaBinduces expression of the Bcl-2 homologue A1", Bfl-1 to preferentiallysuppress chemotherapy-induced apoptosis, 1999, pp.19(9), 5923~5929
  10. "Expression of the neoplastic phenotype by human thyroid carcinomacell lines requires NFkappaB p65 protein expression", 15(16), pp.1987~1994 (1997)
  11. "Tumor necrosis factors alpha and beta protect neurons against amy-loid beta-peptide toxicity evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation", 26(20), pp.9328~9332 (1995)
  12. "Nucleartranslocation of NF-kappaB is increased in dopaminergic neurons ofpatients with parkinson disease", 8, pp.7531~7536 (1997)
  13. "Transcription factor DNA binding activity inPC12 cells undergoing apoptosis after glucose deprivation", 26, pp.137~140 (1995)
  14. "Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced uponapoptosis", 134(1), pp.13~23 (1996)
  15. "NF-kappa B activation mediates doxorubicin-induced cell death inN-type neuroblastoma cells", 28, pp.48921~48959 (2001)
  16. "Tumor necrosisfactor-alpha induces the expression of DR6 a member of the TNFreceptor family through activation of NF-kappaB", 29, pp.7965~7975 (2001)
  17. "Regulation of death receptor expression and TRAIL", Apo2L-inducedapoptosis by NF-kappaB, 2001, pp.3(4), 409~416
  18. "NF-kappaB RelA (p65) is essential for TNF-alpha-induced fas expression butdispensable for both TCR-induced expression and activation-inducedcell death", 166(8), pp.4949~4957 (2001)
  19. "Establishment andcharacterization of nine new head and neck cancer cell lines", 117(5), pp.775~784 (1997)
  20. "4-1BB pro-motes the survival of CD8+ T lymphocytes by increasing expressionof Bcl-xL and Bfl-1", 1, pp.4882~4888 (2002)
  21. "Modulation of cis-diamminedichloroplatinum", pp.227~38
  22. "An essential role for NF-kappaB in preventingTNF-alpha-induced cell death", 1, pp.782~784 (1996)
  23. "Suppression of TNF-alpha-induced apoptosis by NF-kappaB", 1, pp.787~789 (1996)
  24. "TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB", 1, pp.784~787 (1996)
  25. "Constitutively active NFkappa B is required for the survival ofS-type neuroblastoma", 1(277), pp.42144~42150 (2002)
  26. "Activation ofnuclear transcription factor kappa B (NF-kappaB) is essential fordopamine-induced apoptosis in PC12 cells", 77(2), pp.391~398 (2001)
  27. "NF-kappaB is activated and promotes cell death in focal cerebralischemia", 5(5), pp.554~559 (1999)
  28. "IkappaBalpha gene therapy in tumor necrosis factor-alpha- andchemotherapy-mediated apoptosis of hepatocellular carcinomas", 7(10), pp.1315~1323 (2000)
  29. "DNA damaging agents induce expression of Fas ligand and subse-quent apoptosis in T lymphocytes via the activation of NF-kappa Band AP-1", 1(4), pp.543~551 (1998)
  30. "TRAIL and inhibitors of apoptosis are opposing determinants for NF-kappaB-dependent genotoxin-induced apoptosis of cancer cells", 10(21), pp.260~271 (2002)
  31. "Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression", 15(167), pp.3164~3173 (2001)
  32. "NF-kappaB signaling pathway governs TRAIL gene expression and human T-cell leukemia virus-I Tax-induced T-cell death", 2(276), pp.40385~40388 (2001)
  33. "Caspases: killer proteases", 22(8), pp.299~306 (1997)

관련 논문AI추천

사람 구강암종 세포주에서 Non-Steroidal Anti-Inflammatory Drug-Activated Gene(NAG-1)의 유도 및 세포고사 작용김경수, 윤주헌, 이윤재, 이정권, 이주환, 장정현대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2004 · 제47권 제10호구강편평세포암종에서 미슬토 추출물의 Apoptosis 유도 효과에 대한 실험적 연구김철환, 이재훈, 허균행대한구강악안면외과학회 · 대한구강악안면외과학회지2005 · 제31권 제1호구강 편평세포암종 세포주에서 Cyclosporin A와 Taxol 투여시 PI-3 kinase/Akt1 Pathway에 의한 세포사멸 병용효과김규영, 이재훈대한구강악안면외과학회 · 대한구강악안면외과학회지2007 · 제33권 제5호Cyclosporin A가 구강편평상피세포암 세포주에 미치는 항암효과김경욱, 임한욱대한구강악안면외과학회 · 대한구강악안면외과학회지2004 · 제30권 제6호Mode of Cell Death and Molecular Change of Oral Squamous Carcinoma Cells Exposed to Metal Ions김인령, 김형근, 김형일, 박창준, 박혜련대한구강생물학회 · International Journal of Oral Biology2006 · 제31권 제1호선택적 COX-2 저해를 통한 구강암세포주KB의 침습성 변화에 관한 예비연구명훈, 김명진, 이은진대한구강악안면외과학회 · 대한구강악안면외과학회지2007 · 제33권 제2호

이 간행물의 다른 논문 (13건)

가토 악하선 도관 절단술 및 결찰술 후 근상피세포의 변화윤원석, 김철환, 김경욱pp. 81-93구강 편평세포암에서 예후 및 경부임파절 전이와 관련한 증식인자의 발현에 관한 연구서병무, 윤필영, 황순정, 명훈, 김명진, 정필훈, 팽준영, 옥용주, 최진영, 이종호pp. 101-106가토 상악동에 이식된 β-TCP의 골치유에 관한 실험적 연구백승삼, 박정하, 최용수, 박창주, 심광섭, 황경균, 마평수pp. 107-116수종의 항혈전제의 국소 세척이 미세혈관문합의 동맥 치유 및 개존에 미치는 영향김경욱, 김철환, 최용철pp. 117-128하악전돌증 환자에서 악교정수술 후 하악각 및 하악폭경의 변화유선열, 김인호, 한창훈pp. 129-137
원문 보기